{"slideshow_credits": null, "snippet": "The Carlyle Group is near a deal to buy Johnson & Johnson\u2019s clinical testing arm for about $4.1 billion, a person briefed on the matter said on Wednesday.", "abstract": "The Carlyle Group is near a deal to buy Johnson & Johnson\u2019s clinical testing arm for about $4.1 billion, a person briefed on the matter said on Wednesday.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"lastname": "DE LA MERCED", "rank": 1, "firstname": "Michael", "role": "reported", "organization": "", "middlename": "J."}], "original": "By MICHAEL J. DE LA MERCED"}, "web_url": "http://dealbook.nytimes.com/2014/01/15/carlyle-said-to-strike-deal-for-johnson-johnson-testing-division/", "lead_paragraph": null, "headline": {"main": "Carlyle Said to Strike Deal for Johnson & Johnson Testing Division", "print_headline": "Deal Nears", "kicker": "DealBook"}, "_id": "52d7117b38f0d867640260ff", "word_count": "198", "multimedia": [], "pub_date": "2014-01-15T17:51:39Z", "source": "The New York Times", "news_desk": null, "keywords": [{"name": "organizations", "value": "Carlyle Group LP", "rank": "1"}, {"name": "organizations", "value": "Johnson & Johnson", "rank": "2"}, {"name": "subject", "value": "Private Equity", "rank": "2"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}